EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 126 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $511 | -5.0% | 18,017 | -2.2% | 0.00% | 0.0% |
| Q4 2022 | $538 | -99.9% | 18,417 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $487,000 | -40.5% | 18,417 | 0.0% | 0.00% | -50.0% |
| Q2 2022 | $818,000 | -10.2% | 18,417 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $911,000 | -3.4% | 18,417 | -0.5% | 0.00% | 0.0% |
| Q4 2021 | $943,000 | -8.2% | 18,517 | +0.5% | 0.00% | 0.0% |
| Q3 2021 | $1,027,000 | +30.3% | 18,417 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $788,000 | +2.5% | 18,417 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $769,000 | -12.7% | 18,417 | -2.6% | 0.00% | 0.0% |
| Q4 2020 | $881,000 | +9.6% | 18,917 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $804,000 | -12.3% | 18,917 | -1.0% | 0.00% | 0.0% |
| Q2 2020 | $917,000 | +3.3% | 19,117 | -1.0% | 0.00% | -33.3% |
| Q1 2020 | $888,000 | -23.4% | 19,308 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,160,000 | +112.1% | 19,308 | +99.5% | 0.00% | +200.0% |
| Q3 2019 | $547,000 | +1.5% | 9,677 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $539,000 | +10.2% | 9,677 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $489,000 | +28.0% | 9,677 | +2.2% | 0.00% | 0.0% |
| Q4 2018 | $382,000 | -41.6% | 9,469 | +0.5% | 0.00% | -50.0% |
| Q3 2018 | $654,000 | -0.8% | 9,426 | +8.2% | 0.00% | 0.0% |
| Q2 2018 | $659,000 | +26.2% | 8,715 | -12.1% | 0.00% | +100.0% |
| Q1 2018 | $522,000 | +12.0% | 9,915 | +13.8% | 0.00% | 0.0% |
| Q4 2017 | $466,000 | -8.6% | 8,715 | +1.8% | 0.00% | 0.0% |
| Q3 2017 | $510,000 | -39.9% | 8,557 | -20.5% | 0.00% | -50.0% |
| Q2 2017 | $849,000 | +2.8% | 10,757 | +8.0% | 0.00% | 0.0% |
| Q1 2017 | $826,000 | +4.6% | 9,957 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $790,000 | +15.7% | 9,957 | +2.0% | 0.00% | 0.0% |
| Q3 2016 | $683,000 | +2339.3% | 9,757 | +1293.9% | 0.00% | – |
| Q1 2016 | $28,000 | – | 700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 400,000 | $5,732,000 | 1.52% |
| Park West Asset Management LLC | 426,900 | $6,117,000 | 0.80% |
| WALL STREET ASSOCIATES | 200,000 | $2,866,000 | 0.25% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 284,653 | $4,079,000 | 0.16% |
| FARALLON CAPITAL MANAGEMENT LLC | 100,000 | $1,433,000 | 0.02% |
| NEXT Financial Group, Inc | 2,500 | $26,000 | 0.01% |
| PIPER SANDLER & CO. | 1,277 | $18,000 | 0.01% |
| Ground Swell Capital, LLC | 400 | $6,000 | 0.01% |
| PARADIGM ASSET MANAGEMENT CO LLC | 6,300 | $90,279,000 | 0.01% |
| Paloma Partners Management Co | 14,363 | $206,000 | 0.01% |